SCHEMBL24907168

SCHEMBL24907168

CC1NC(=O)CC1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 2/20 0.42
ITGA5 P08648 2/20 0.42
ITGB3 P05106 1/20 0.42
ITGB2 P05107 1/20 0.42
ITGAV P06756 1/20 0.42
ITGA2B P08514 1/20 0.42
ITGB5 P18084 1/20 0.42
ITGAL P20701 1/20 0.42
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CRBN Q96SW2 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
BRD4 O60885 4/20 0.32
CREBBP Q92793 3/20 0.32
EP300 Q09472 1/20 0.32
SLC5A1 P13866 1/20 0.32
CAD P27708 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12962517 1.00 ITGB1 (0.42) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL21436951 0.81 EPHX1 (0.38) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL23002170 0.79 POLB (0.35) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL17925905 0.78 ALDH1A1 (0.38) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL14827814 0.77 CRBN (0.33) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL6405736 0.76 ITGB1 (0.43) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL6405731 0.76 ITGB1 (0.43) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL25851247 0.74 ALDH1A1 (0.38) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL16876469 0.74 MEN1 (0.41) ITGB1ITGA5ITGB3ITGB2ITGAV
SCHEMBL23002182 0.71 ALDH1A1 (0.39) ITGB1ITGA5ITGB3ITGB2ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 CN disclosed
US-20230227405-A1 5-OXOPYRROLIDINE-3-CARBOXAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-07-20 US disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 US disclosed
US-20230014907-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMACEUTICALS INCORPORATED 2023-01-19 US disclosed
EP-4114375-A1 FERROPTOSIS INHIBITORS-DIARYLAMINE PARA-ACETAMIDES Sironax Ltd (KY) 2023-01-11 EP disclosed
CN-115151252-A Iron death inhibitors diarylamine para-acetamides 维泰瑞隆有限公司 2022-10-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230014907-A1 INHIBITORS OF APOL1 AND METHODS OF USING SAME APOL1, APOB, NPC1L1 ITGB1 663/4885ITGA5 2260/4885ITGB3 2019/4885
US-20230227405-A1 5-OXOPYRROLIDINE-3-CARBOXAMIDES AS NAV1.8 INHIBITORS SCN8A, TRPV1, SCN5A ITGB1 3839/4885ITGA5 2299/4885ITGB3 3960/4885
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 ITGB1 4812/4885ITGA5 4806/4885ITGB3 4829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.